-
Jan 3, 2025 | 
healio.com | Nathan M. Radcliffe |Anthony DeFino
You've successfully added to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. NEW YORK — In this presentation from OSN New York,Nathan M. Radcliffe, MD, shares pearls for effective use of the Durysta implant for treating glaucoma.
-
Oct 31, 2024 | 
glaucomaphysician.net | Nathan M. Radcliffe
How does one treat glaucoma? Of course, the only proven therapy at this point in time is lowering intraocular pressure (IOP). My favorite answer to this question has always been that the goal of glaucoma treatment is to maintain the patient’s vision-related quality of life without decreasing the patient’s quality of life. With this goal in mind, the practical answer is to lower IOP in a way that maximizes the patient’s overall quality of life.
-
Aug 21, 2024 | 
healio.com | Kenneth Beckman |I. Paul Singh |Nathan M. Radcliffe |Christine Klimanskis
You've successfully added to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Welcome to another edition of CEDARS/ASPENS Debates. CEDARS/ASPENS is a society of cornea, cataract and refractive surgery specialists, here to discuss some of the latest hot topics in ophthalmology.
-
May 31, 2024 | 
glaucomaphysician.net | Nathan M. Radcliffe
If you look at the evolving treatment landscape in glaucoma from 30,000 feet, a few things seem obvious. The first is that selective laser trabeculoplasty (SLT) is moving into the position of primary therapy, standing on the shoulders of the prospective multicenter LiGHT trial.1 Even this relatively straightforward change will result in dramatic adaptations from ophthalmologists a well as optometrists.
-
May 21, 2024 | 
eyetube.net | Arsham Sheybani |Nathan M. Radcliffe
Reflections on the Reimbursement Landscape Iqbal Ike K. Ahmed, MD, FRCSC; Arsham Sheybani, MD; and Nathan M. Radcliffe, MD Show Description + Nathan Radcliffe, MD, sits down with Iqbal Ike K. Ahmed, MD, FRCSC, and Arsham Sheybani, MD, to reflect on the status of reimbursements for glaucoma procedures. He explains how the ASCRS, AAO, and AGS pooled resources to advocate for and provide stronger efficacy evidence of goniotomy, canaloplasty, and laser treatments.
-
Apr 12, 2024 | 
healio.com | Alex Young |Christine Klimanskis |Nathan M. Radcliffe
You've successfully added to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Key takeaways: A study looked at real-world outcomes with Omni, Hydrus, iStent inject and cataract surgery. Patients treated with the Omni surgical system had the greatest reduction in IOP and medication use.
-
Mar 1, 2024 | 
glaucomaphysician.net | Nathan M. Radcliffe
As we approach the era of interventional glaucoma, it’s worth taking a moment to consider some of our headwinds and tailwinds. Innovation, careful research, and the minimally invasive glaucoma surgery (MIGS) revolution have given us new tools. There is solid support that, given the tolerability and compliance challenges of topical therapy, earlier intervention with safe glaucoma procedures can lead to better outcomes.
-
Feb 9, 2024 | 
healio.com | Nathan M. Radcliffe |Anthony DeFino |Eamon Dreisbach
You've successfully added to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. WAILEA, Hawaii — In this Healio Video Perspective from Hawaiian Eye/Retina 2024, Nathan M. Radcliffe, MD, discusses the recent threats to reimbursement for minimally invasive glaucoma surgery procedures.
-
Feb 7, 2024 | 
healio.com | Anthony DeFino |David Mullin |Nathan M. Radcliffe
Nathan M. Radcliffe, MD After a 4-month fight with glaucoma clinicians, their patients, patient advocacy groups and political representatives, the five MACs proposing draconian cutbacks for MIGS have withdrawn their proposed LCD changes. The MAC LCDs recommended significant cutbacks to canaloplasty, cyclophotocoagulation and goniotomy and received an overwhelming outpouring of disapproval from clinicians.
-
Jan 14, 2024 | 
healio.com | Nathan M. Radcliffe |Anthony DeFino |Eamon Dreisbach
You've successfully added Ophthalmology: Glaucoma to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. WAILEA, Hawaii — In this Healio Video Perspective from Hawaiian Eye/Retina 2024, Nathan M.
